Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Anthropometric measurements and a nutritional assessment were performed at T1 and T4
A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy
R.WalickiJ.GreyC.BarluengaS.WinssingerN.et al (2010)
10.3390/molecules15031242 39 CahillL.HallE
Read what others say : Look up reviews on Google or social media
PubMed PMID: 35013352
US$ 26.07
US$ 24.52
US$ 24.73
US$ 28.62
US$ 21.98
US$ 28.03
US$ 24.45
US$ 21.88
